Monoclonal antibodies targeting Clostridium difficile licensed to Merck.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D016360:Clostridioides difficile / Q000254:growth & development* / Q000276:immunology*; D004338:Drug Combinations; D016503:Drug Delivery Systems; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D006801:Humans
D000911:Antibodies, Monoclonal; D004338:Drug Combinations